Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2017

Jan 3, 2017

32414_dirs_2017-01-03_2bfcff56-e485-4beb-96b1-130a18db5874.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2016-12-29

Reporting Person: Grooms Jamie Mark (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-12-29 Stock Option (right to purchase) $8.95 A 5000 Acquired 2026-12-29 Common Stock (5000) Direct

Footnotes

F1: Non-qualified stock option grant for service as Director on Company's Board of directors. Vesting is 100% upon the director's re-election to the Company's Board of Directors at the 2017 Annual Meeting of Shareholders.